Challenges Remain for Improving Non-Hodgkin Lymphoma Treatments

A roundtable discussion, moderated by Kami J. Maddocks, MD, of the James Cancer Hospital, Ohio State University Comprehensive Cancer Center, focused on treatment options for diffuse large B-cell lymphoma and follicular lymphoma, including novel emerging therapies and treatment sequencing considerations. Dr. Maddocks was joined by a panel that included Pierluigi Porcu, MD; Pamela Blair Allen, MD, MSc; and Jonathan W. Friedberg, MD.
In the next segment, the panel discusses barriers to improving treatment options for patients with DLBCL and follicular lymphoma, including clinical trial participation challenges.